Generic Logo

Working At Depomed

Zippia Score 4.3

Depomed overview

Depomed, Inc., a specialty pharmaceutical company, engages in the development, sale, and licensing of products for pain and other central nervous system conditions in the United States. It offers Gralise (gabapentin), an once-daily product for the management of postherpetic neuralgia; CAMBIA (diclofenac potassium for oral solution), a non-steroidal anti-inflammatory drug indicated for acute treatment of migraine attacks in adults; Zipsor (diclofenac potassium) liquid filled capsule, a non-steroidal anti-inflammatory drug for the treatment of mild to moderate acute pain in adults; and Lazanda (fentanyl) nasal spray, an intranasal fentanyl drug used to manage breakthrough pain in adults. The company also provides NUCYNTA ER (tapentadol extended release tablets), a product for the management of pain severe enough to long term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults; and NUCYNTA (tapentadol), a product for the management of moderate to severe acute pain in adults. In addition, it is involved in the clinical development of Cebranopadol for the treatment of chronic nociceptive and neuropathic pain. The company sells its products to wholesalers and retail pharmacies. It also has a portfolio of license agreements based on its proprietary Acuform gastroretentive drug delivery technology with Mallinckrodt Inc.; Ironwood Pharmaceuticals, Inc.; and Janssen Pharmaceuticals, Inc. The company was founded in 1995 and is headquartered in Newark, California.
Founded in 1995, Depomed is an established company that loves to hire graduates from California State University - East Bay, with 7.0% of its employees having attended California State University - East Bay. Want to compare Depomed to some other great places to work in the United States? We suggest taking a look at Zippia's list of Best Companies to Work For in the United States. The average employee at Depomed makes $65,181 per year. Pay at Depomed is significantly lower than some of its highest paying competitors, like Arbor Pharmaceuticals, Xanodyne Pharmaceuticals, and AstraZeneca, which pay $104,855, $95,245, and $88,191, respectively.
Depomed is a medium pharmaceutical company with 490 employees and an annual revenue of $425.3M that is headquartered in the United States.

The Organization’s Mission

Depomed is a growth - oriented, CNS focused specialty pharmaceutical company that develops and commercializes innovative products that address unmet medical needs.







Founded in






Organization Type


Is This Your Company?

The team at Depomed

What do people say about Depomed

Do you work at Depomed ? Anonymously review Depomed as an Employer.

What Do You Like About Working For Depomed?

Depomed careers

On average, employees at Depomed stay with the company for 2.1 years. Employees most commonly join Depomed after leaving Pfizer. When they leave Depomed, they most frequently get their next job at Endo Pharmaceuticals.

Average Length of Employment


2.1 years
Top Employers Before Depomed
Pfizer10.2 %
Show More
Top Employers After Depomed
Durect5.9 %
Show More

Do you Work At Depomed?

Help us make this company more transparent.

Depomed Financial Performance

Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.


$100M - $1B

Founded in


Organization type


How Would You Rate The Company Culture Of Depomed?

Have you worked at Depomed? Help other job seekers by rating Depomed.

Depomed Competitors

Frequently Asked Questions about Depomed

When was Depomed founded?

Depomed was founded in 1995.

How many Employees does Depomed have?

Depomed has 490 employees.

How much money does Depomed make?

Depomed generates $425.3M in revenue.

What industry is Depomed in?

Depomed is in the pharmaceuticals industry.

What is Depomed's mission?

Depomed's mission statement is "Depomed is a growth - oriented, CNS focused specialty pharmaceutical company that develops and commercializes innovative products that address unmet medical needs."

What type of company is Depomed?

Depomed is a public company.

Who are Depomed's competitors?

Depomed competitors include Arbor Pharmaceuticals, LLC, Odyssey Pharmaceutical, Noven Pharmaceuticals Inc., Endo Pharmaceuticals, Organon, Daiichi Sankyo, Xanodyne Pharmaceuticals Inc., Shionogi, Mylan Specialty LP, Ferring Pharmaceuticals Inc., Supernus Pharmaceuticals Inc., AstraZeneca, KV Pharmaceutical, Ucb, Forest Pharmaceuticals Inc., Boehringer Ingelheim Corporation, ALZA Corporation, KOREA DAIICHI PHARM COLTD, Cumberland Pharmaceuticals Inc., Mission Pharmacal Company.

What is Depomed's website?

You can find the Depomed website at

Are you an executive, HR leader, or brand manager at Depomed?

Claiming and updating your company profile on Zippia is free and easy.

You can find out what it is like to work at Depomed, also known as DEPOMED INC, DepoMed Inc, Depomed and Depomed Inc.

Zippia gives an in-depth look into the details of Depomed, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Depomed. The employee data is based on information from people who have self-reported their past or current employments at Depomed. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions, or for the results obtained from the use of this information. The data presented on this page does not represent the view of Depomed and its employees or that of Zippia.